Extracellular vesicles (EVs) are small membrane-bound vesicles secreted into the
extracellular space by all cell types. EVs transfer their cargo which includes nucleic acids …

Extracellular vesicles (EVs) are widely recognized for their potential as drug delivery
systems. EVs are membranous nanoparticles shed from cells. Among their natural features …

The molecular heterogeneity of extracellular vesicles (EVs) and the co‐isolation of
physically similar particles, such as lipoproteins (LPs), confounds and limits the sensitivity of …

Macrophages are important antigen presenting cells which can release extracellular
vesicles (EVs) carrying functional cargo including non‐coding RNAs. Macrophages can be …

Mesenchymal stem/stromal cells (MSCs) are multipotent somatic cells that have been widely
explored in the field of regenerative medicine. MSCs possess the ability to secrete soluble …

Post-transcriptional regulation by non-coding RNAs (ncRNAs) can modulate the expression
of genes involved in kidney physiology and disease. A large variety of ncRNA species exist …

Extracellular vesicles (EVs) are nanoparticles released from various cell types that have
emerged as powerful new therapeutic option for a variety of diseases. EVs are involved in …

Therapeutic genome editing has the potential to cure diseases by directly correcting genetic
mutations in tissues and cells. Recent progress in the clustered regularly interspaced short …

Breast cancer (BC), a heterogeneous group of diseases, is the most frequent type and the
leading cause of cancer-related death among women worldwide. Tumor heterogeneity …

Introduction The hunt for new biomarkers–for the diagnosis of subcategories of disease, or
for the monitoring of the efficacy of novel therapeutics–is an increasingly relevant challenge …